Author:
Li Yan,Yang Shouyan,Yue Honggang,Yuan Dandi,Li Luxia,Zhao Jinghong,Zhao Lintao
Funder
National Natural Science Foundation of China
the Research on The Basis and Frontier of Chongqing
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine,Pathology and Forensic Medicine
Reference28 articles.
1. Frew IJ, Moch H (2015) A clearer view of the molecular complexity of clear cell renal cell carcinoma. Annu Rev Pathol 10:263–289
2. Hecht JR. Current and emerging therapies for metastatic colorectal cancer: applying research findings to clinical practice. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2008;65:S15–21; quiz S2–4
3. Buczek M, Escudier B, Bartnik E, Szczylik C, Czarnecka A (1845) Resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma: from the patient's bed to molecular mechanisms. Biochim Biophys Acta 2014:31–41
4. Ciccarese C, Massari F, Santoni M, Heng DY, Sotte V, Brunelli M et al (2015) New molecular targets in non clear renal cell carcinoma: an overview of ongoing clinical trials. Cancer Treat Rev 41:614–622
5. Vermassen T, De Meulenaere A, Van de Walle M, Rottey S (2017) Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma. Acta Clin Belg 72:12–18
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献